Webbticagrelor ticagrelor [ema epar] ticagrelor [ep monograph] ticagrelor [jan] ticagrelor [mart.] ticagrelor [mi] ticagrelor [orange book] ticagrelor [usan] ticagrelor [usp-rs] ticagrelor [vandf] ticagrelor [who-dd] ticagrelor [inn] cas登记号: 274693-27-5: 物质唯一标识(unique ingredient identifier) glh0314rvc: 分子式: c23h28f2n6o4s WebbTicagrelor Zentiva, Filmdragerad tablett 90 mg . Zentiva ApS. Brilique (Tikagrelor) Brilique, Munsönderfallande tablett 90 mg . AstraZeneca. Avregistrerade läkemedel (1) POSSIA (Tikagrelor) POSSIA, Filmdragerad tablett 90 mg . AstraZeneca. Substans (1) Tikagrelor. Sjukdom (0) Om Läkemedel
Food and Drug Administration
WebbTICAGRELOR. FDA全球物质注册数据库(FDA Global Substance Registration System). 物质名称. TICAGRELOR. 异名/同义词. (1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4 … Webb10 feb. 2024 · Duration of Action. IPA: 180 mg loading dose: 87% to 89% maintained from 2 to 8 hours; 24 hours after the last maintenance dose, IPA is 58% (similar to maintenance dosing for clopidogrel) Time after discontinuation when IPA is 30%: ~56 hours; IPA 10%: ~110 hours (Gurbel 2009). christmas decorations silver and blue
European Pharmacopoeia Online - EDQM
WebbTicagrelor European Pharmacopoeia (EP) Reference Standard; CAS Number: 274693-27-5; Synonyms: (1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino}-5 … WebbTICAGRELOR [EP MONOGRAPH] TICAGRELOR [INN] TICAGRELOR [JAN] TICAGRELOR [MART.] TICAGRELOR [MI] TICAGRELOR [ORANGE BOOK] TICAGRELOR [USAN] … WebbTicagrelor (known trade names Brilinta, Brilique and Possia) is a P2Y12 platelet inhibitor. Brilinta has been approved by the US Food and Drug administration (FDA) in 2011 and is indicated to reduce the rate of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction. germany wallet